Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

Paul L. Moots; Anne O’Neill; Harold Londer; Minesh Mehta; Deborah T. Blumenthal; Geoffrey R. Barger; Margaret L. Grunnet; Stuart Grossman; Mark R. Gilbert; David Schiff

doi:10.1097/COC.0000000000000326

Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

Paul L. Moots, Anne O’Neill, Harold Londer, Minesh Mehta, Deborah T. Blumenthal, Geoffrey R. Barger, Margaret L. Grunnet, Stuart Grossman, Mark R. Gilbert, David Schiff

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	American Journal of Clinical Oncology
DOIs	https://doi.org/10.1097/COC.0000000000000326
State	Published - Jan 9 2016

Disciplines

Oncology
Medicine and Health Sciences

Access to Document

10.1097/COC.0000000000000326License: Unspecified

Cite this

@article{6b59ce422a974da0b8daaf8ed0d53c84,

title = "Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).",

author = "Moots, \{Paul L.\} and Anne O{\textquoteright}Neill and Harold Londer and Minesh Mehta and Blumenthal, \{Deborah T.\} and Barger, \{Geoffrey R.\} and Grunnet, \{Margaret L.\} and Stuart Grossman and Gilbert, \{Mark R.\} and David Schiff",

note = "OBJECTIVES:: To assess the long-term outcomes and objective response (OR) to preradiation chemotherapy and radiation in adult high-risk medulloblastoma. MATERIALS AND METHODS:: In this prospective phase II trial, adults with high-risk medulloblastoma were treated with 3 cycles of preradiation cisplatin, etoposide, cyclophosphamide, and vincristine followed by craniospinal radiation (CSI).",

year = "2016",

month = jan,

day = "9",

doi = "10.1097/COC.0000000000000326",

language = "American English",

journal = "American Journal of Clinical Oncology",

}

TY - JOUR

T1 - Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

AU - Moots, Paul L.

AU - O’Neill, Anne

AU - Londer, Harold

AU - Mehta, Minesh

AU - Blumenthal, Deborah T.

AU - Barger, Geoffrey R.

AU - Grunnet, Margaret L.

AU - Grossman, Stuart

AU - Gilbert, Mark R.

AU - Schiff, David

N1 - OBJECTIVES:: To assess the long-term outcomes and objective response (OR) to preradiation chemotherapy and radiation in adult high-risk medulloblastoma. MATERIALS AND METHODS:: In this prospective phase II trial, adults with high-risk medulloblastoma were treated with 3 cycles of preradiation cisplatin, etoposide, cyclophosphamide, and vincristine followed by craniospinal radiation (CSI).

PY - 2016/1/9

Y1 - 2016/1/9

UR - https://jhu.pure.elsevier.com/en/publications/preradiation-chemotherapy-for-adult-high-risk-medulloblastoma-a-t

U2 - 10.1097/COC.0000000000000326

DO - 10.1097/COC.0000000000000326

M3 - Article

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

ER -

Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

Disciplines

Access to Document

Other files and links

Cite this